Nowicki Kamil W, Mittal Aditya M, Abou-Al-Shaar Hussam, Rochlin Emma K, Lang Michael J, Gross Bradley A, Friedlander Robert M
Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Loyola University Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA.
Cell Mol Neurobiol. 2023 Aug;43(6):2697-2711. doi: 10.1007/s10571-023-01346-4. Epub 2023 Apr 12.
Intracranial aneurysms are reported to affect 2-5% of the population. Despite advances in the surgical management of this disease, diagnostic technologies have marginally improved and still rely on expensive or invasive imaging procedures. Currently, there is no blood-based test to detect cerebral aneurysm formation or quantify the risk of rupture. The aim of this review is to summarize current literature on the mechanism of aneurysm formation, specifically studies relating to inflammation, and provide a rationale and commentary on a hypothetical future blood-based test. Efforts should be focused on clinical-translational approaches to create an assay to screen for cerebral aneurysm presence and risk-stratify patients to allow for superior treatment timing and management. Cerebral Aneurysm Blood Test Considerations: There are multiple caveats to development of a putative blood test to detect cerebral aneurysm presence.
据报道,颅内动脉瘤在人群中的发病率为2%至5%。尽管该疾病的外科治疗取得了进展,但诊断技术的改善甚微,仍依赖于昂贵或侵入性的成像检查。目前,尚无基于血液的检测方法来检测脑动脉瘤的形成或量化破裂风险。本综述的目的是总结目前关于动脉瘤形成机制的文献,特别是与炎症相关的研究,并对未来基于血液的检测方法提出理论依据和评论。应致力于临床转化方法,以创建一种检测方法来筛查脑动脉瘤的存在,并对患者进行风险分层,从而实现更优的治疗时机和管理。脑动脉瘤血液检测的考虑因素:开发一种用于检测脑动脉瘤存在的假定血液检测方法存在多个需要注意的问题。